Compare Ravinder Heights with Similar Stocks
Dashboard
Poor Management Efficiency with a low ROE of 2.66%
- The company has been able to generate a Return on Equity (avg) of 2.66% signifying low profitability per unit of shareholders funds
With ROE of 10.3, it has a Very Expensive valuation with a 0.8 Price to Book Value
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
Ravinder Heights for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Ravinder Heights Ltd Upgraded to Hold as Technicals Improve Amid Mixed Financial Signals
Ravinder Heights Ltd, a player in the realty sector, has seen its investment rating upgraded from Sell to Hold as of 5 January 2026. This change reflects a nuanced improvement across technical indicators, financial trends, valuation metrics, and overall quality assessments, signalling a cautious but positive outlook for investors.
Read full news article
Ravinder Heights Ltd Downgraded to Sell Amid Technical Weakness and Valuation Concerns
Ravinder Heights Ltd, a player in the realty sector, has seen its investment rating downgraded from Hold to Sell as of 31 Dec 2025, reflecting a shift in technical indicators and valuation concerns despite strong recent financial growth. The company’s Mojo Score has dropped to 47.0, signalling caution for investors amid a mildly bearish technical outlook and valuation challenges.
Read full news article
Ravinder Heights Ltd is Rated Hold
Ravinder Heights Ltd is rated Hold by MarketsMOJO. This rating was last updated on 24 Nov 2025. However, the analysis and financial metrics discussed below reflect the company’s current position as of 27 December 2025, providing investors with the latest insights into its performance and outlook.
Read full news article Announcements 
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
12-Jan-2026 | Source : BSECompliance Certificate received under R. 74(5) of SEBI(DP) Regulations 2018 for the quarter and Nine Month ended December 31 2025
Closure of Trading Window
26-Dec-2025 | Source : BSEClosure of Trading Window
Announcement under Regulation 30 (LODR)-Change in Management
16-Dec-2025 | Source : BSEAppointment of Mr. Chander Mohan Mehra(DIN:07173867) as a Non-Executive Independent Director through shareholders approval by way of postal ballot dated 12th November 2025
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Sunanda Jain (74.74%)
Serum Institute Of India Private Limited (4.58%)
16.38%
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is 42,215.38% vs -7.14% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is 7,767.31% vs 42.86% in Jun 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 18,280.00% vs -6.25% in Sep 2024
Growth in half year ended Sep 2025 is 8,472.34% vs -135.00% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'24
YoY Growth in nine months ended Dec 2024 is -6.38% vs 74.07% in Dec 2023
YoY Growth in nine months ended Dec 2024 is 11.96% vs -135.90% in Dec 2023
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is -8.06% vs -94.85% in Mar 2024
YoY Growth in year ended Mar 2025 is -18.14% vs -134.85% in Mar 2024






